Effects of nocturnal melatonin-based tissue-bone homeostasis manipulation at varying time points on pain and central mechanisms in individuals with knee osteoarthritis: a randomized controlled trial

夜间褪黑激素调节组织-骨稳态在不同时间点对膝骨关节炎患者疼痛和中枢机制的影响:一项随机对照试验

阅读:1

Abstract

BACKGROUND: Tissue-bone homeostasis manipulation (TBHM) has been proven effective for knee osteoarthritis (KOA), but its optimal timing and underlying mechanisms remain unclear. Melatonin serves as a key biomarker of circadian rhythm, while electroencephalography (EEG) evaluates pain-related central mechanisms. This study investigated the efficacy of TBHM at different time points based on circadian principles and explored potential central mechanisms using EEG. METHODS: In this 4-week randomized controlled single-blind trial, 88 KOA patients were randomized into four groups: group A (TBHM at 8 a.m.), group B (TBHM at 1 p.m.), group C (TBHM at 6 p.m.), and group D (joint mobilization). Interventions were administered once daily (20 min/session, 5 days/week). Primary outcome was Visual Analog Scale (VAS) for pain; secondary outcomes were resting-state EEG and Hamilton Anxiety Rating Scale. Salivary melatonin levels were measured to explore circadian mechanisms. Assessments were conducted at baseline and after 4 weeks. Statistical analyses employed two-way repeated-measures ANOVA. RESULTS: Of the 88 patients randomized, 82 completed the study. After 4 weeks, all groups showed reduced VAS scores and increased melatonin levels. Post-treatment, group C exhibited significantly lower VAS scores than group B (FDR adjusted P = 0.023), and group B had significantly lower VAS scores than group A (FDR adjusted P = 0.037). Although group A showed lower scores than group D, the difference was not statistically significant (FDR adjusted P > 0.05). Melatonin levels increased significantly in the three TBHM groups after treatment. group C was demonstrated significantly higher melatonin levels than group B (FDR adjusted P < 0.001), group B was significantly higher than group A (FDR adjusted P = 0.007), and group A was higher than group D (FDR adjusted P = 0.026). After treatment, a decrease in β band activity and an increase in θ band activity were observed in the frontal and central regions of groups C and B in EEG analysis, but there was no significant difference (FDR adjusted P > 0.05). CONCLUSION: The TBHM at all time points can better improve the pain of KOA patients than joint mobilization, regulate cortical electrical activity, and increase the secretion of melatonin at night. TRIAL REGISTRATION: ChiCTR2400080820. Registered on Feb.07,2024.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。